Agomab bolsters executive team with appointment of pierre kemula as chief financial officer

Antwerp, belgium--(business wire)--agomab therapeutics nv (‘agomab') today announced that pierre kemula will join the company as chief financial officer (cfo) effective november 1, 2024, bringing more than 15 years of experience in global biotech financial leadership. mr. kemula joins agomab from curevac n.v. (nasdaq: cvac), where he currently serves as cfo. in this role, mr. kemula has led curevac's financial and capital markets activities since 2016, characterized by a successful listing on n.
CVAC Ratings Summary
CVAC Quant Ranking